1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Human Blood Plasma Fractionation Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Immune Globulin 1.2.3 Coagulation Factor 1.2.4 Albumin 1.2.5 Other 1.3 Market by Application 1.3.1 Global Human Blood Plasma Fractionation Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Retail Pharmacy 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Human Blood Plasma Fractionation Market Perspective (2017-2028) 2.2 Human Blood Plasma Fractionation Growth Trends by Region 2.2.1 Human Blood Plasma Fractionation Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Human Blood Plasma Fractionation Historic Market Size by Region (2017-2022) 2.2.3 Human Blood Plasma Fractionation Forecasted Market Size by Region (2023-2028) 2.3 Human Blood Plasma Fractionation Market Dynamics 2.3.1 Human Blood Plasma Fractionation Industry Trends 2.3.2 Human Blood Plasma Fractionation Market Drivers 2.3.3 Human Blood Plasma Fractionation Market Challenges 2.3.4 Human Blood Plasma Fractionation Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Human Blood Plasma Fractionation Players by Revenue 3.1.1 Global Top Human Blood Plasma Fractionation Players by Revenue (2017-2022) 3.1.2 Global Human Blood Plasma Fractionation Revenue Market Share by Players (2017-2022) 3.2 Global Human Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Human Blood Plasma Fractionation Revenue 3.4 Global Human Blood Plasma Fractionation Market Concentration Ratio 3.4.1 Global Human Blood Plasma Fractionation Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Human Blood Plasma Fractionation Revenue in 2021 3.5 Human Blood Plasma Fractionation Key Players Head office and Area Served 3.6 Key Players Human Blood Plasma Fractionation Product Solution and Service 3.7 Date of Enter into Human Blood Plasma Fractionation Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Human Blood Plasma Fractionation Breakdown Data by Type 4.1 Global Human Blood Plasma Fractionation Historic Market Size by Type (2017-2022) 4.2 Global Human Blood Plasma Fractionation Forecasted Market Size by Type (2023-2028) 5 Human Blood Plasma Fractionation Breakdown Data by Application 5.1 Global Human Blood Plasma Fractionation Historic Market Size by Application (2017-2022) 5.2 Global Human Blood Plasma Fractionation Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Human Blood Plasma Fractionation Market Size (2017-2028) 6.2 North America Human Blood Plasma Fractionation Market Size by Country (2017-2022) 6.3 North America Human Blood Plasma Fractionation Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Human Blood Plasma Fractionation Market Size (2017-2028) 7.2 Europe Human Blood Plasma Fractionation Market Size by Country (2017-2022) 7.3 Europe Human Blood Plasma Fractionation Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Human Blood Plasma Fractionation Market Size (2017-2028) 8.2 Asia-Pacific Human Blood Plasma Fractionation Market Size by Country (2017-2022) 8.3 Asia-Pacific Human Blood Plasma Fractionation Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Human Blood Plasma Fractionation Market Size (2017-2028) 9.2 Latin America Human Blood Plasma Fractionation Market Size by Country (2017-2022) 9.3 Latin America Human Blood Plasma Fractionation Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Human Blood Plasma Fractionation Market Size (2017-2028) 10.2 Middle East & Africa Human Blood Plasma Fractionation Market Size by Country (2017-2022) 10.3 Middle East & Africa Human Blood Plasma Fractionation Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Takeda 11.1.1 Takeda Company Detail 11.1.2 Takeda Business Overview 11.1.3 Takeda Human Blood Plasma Fractionation Introduction 11.1.4 Takeda Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.1.5 Takeda Recent Development 11.2 CSL 11.2.1 CSL Company Detail 11.2.2 CSL Business Overview 11.2.3 CSL Human Blood Plasma Fractionation Introduction 11.2.4 CSL Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.2.5 CSL Recent Development 11.3 Grifols 11.3.1 Grifols Company Detail 11.3.2 Grifols Business Overview 11.3.3 Grifols Human Blood Plasma Fractionation Introduction 11.3.4 Grifols Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.3.5 Grifols Recent Development 11.4 Octapharma 11.4.1 Octapharma Company Detail 11.4.2 Octapharma Business Overview 11.4.3 Octapharma Human Blood Plasma Fractionation Introduction 11.4.4 Octapharma Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.4.5 Octapharma Recent Development 11.5 Kedrion 11.5.1 Kedrion Company Detail 11.5.2 Kedrion Business Overview 11.5.3 Kedrion Human Blood Plasma Fractionation Introduction 11.5.4 Kedrion Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.5.5 Kedrion Recent Development 11.6 LFB Group 11.6.1 LFB Group Company Detail 11.6.2 LFB Group Business Overview 11.6.3 LFB Group Human Blood Plasma Fractionation Introduction 11.6.4 LFB Group Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.6.5 LFB Group Recent Development 11.7 Biotest 11.7.1 Biotest Company Detail 11.7.2 Biotest Business Overview 11.7.3 Biotest Human Blood Plasma Fractionation Introduction 11.7.4 Biotest Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.7.5 Biotest Recent Development 11.8 BPL 11.8.1 BPL Company Detail 11.8.2 BPL Business Overview 11.8.3 BPL Human Blood Plasma Fractionation Introduction 11.8.4 BPL Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.8.5 BPL Recent Development 11.9 RAAS 11.9.1 RAAS Company Detail 11.9.2 RAAS Business Overview 11.9.3 RAAS Human Blood Plasma Fractionation Introduction 11.9.4 RAAS Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.9.5 RAAS Recent Development 11.10 CBPO 11.10.1 CBPO Company Detail 11.10.2 CBPO Business Overview 11.10.3 CBPO Human Blood Plasma Fractionation Introduction 11.10.4 CBPO Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.10.5 CBPO Recent Development 11.11 Hualan Bio 11.11.1 Hualan Bio Company Detail 11.11.2 Hualan Bio Business Overview 11.11.3 Hualan Bio Human Blood Plasma Fractionation Introduction 11.11.4 Hualan Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.11.5 Hualan Bio Recent Development 11.12 Tiantan Bio 11.12.1 Tiantan Bio Company Detail 11.12.2 Tiantan Bio Business Overview 11.12.3 Tiantan Bio Human Blood Plasma Fractionation Introduction 11.12.4 Tiantan Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.12.5 Tiantan Bio Recent Development 11.13 Shuanglin Bio 11.13.1 Shuanglin Bio Company Detail 11.13.2 Shuanglin Bio Business Overview 11.13.3 Shuanglin Bio Human Blood Plasma Fractionation Introduction 11.13.4 Shuanglin Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.13.5 Shuanglin Bio Recent Development 11.14 Boya Bio 11.14.1 Boya Bio Company Detail 11.14.2 Boya Bio Business Overview 11.14.3 Boya Bio Human Blood Plasma Fractionation Introduction 11.14.4 Boya Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.14.5 Boya Bio Recent Development 11.15 Yuanda Shuyang 11.15.1 Yuanda Shuyang Company Detail 11.15.2 Yuanda Shuyang Business Overview 11.15.3 Yuanda Shuyang Human Blood Plasma Fractionation Introduction 11.15.4 Yuanda Shuyang Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.15.5 Yuanda Shuyang Recent Development 11.16 Weiguang Bio 11.16.1 Weiguang Bio Company Detail 11.16.2 Weiguang Bio Business Overview 11.16.3 Weiguang Bio Human Blood Plasma Fractionation Introduction 11.16.4 Weiguang Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.16.5 Weiguang Bio Recent Development 11.17 Nanyue Bio 11.17.1 Nanyue Bio Company Detail 11.17.2 Nanyue Bio Business Overview 11.17.3 Nanyue Bio Human Blood Plasma Fractionation Introduction 11.17.4 Nanyue Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.17.5 Nanyue Bio Recent Development 11.18 KM Biologics 11.18.1 KM Biologics Company Detail 11.18.2 KM Biologics Business Overview 11.18.3 KM Biologics Human Blood Plasma Fractionation Introduction 11.18.4 KM Biologics Revenue in Human Blood Plasma Fractionation Business (2017-2022) 11.18.5 KM Biologics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Human Blood Plasma Fractionation Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Immune Globulin Table 3. Key Players of Coagulation Factor Table 4. Key Players of Albumin Table 5. Key Players of Other Table 6. Global Human Blood Plasma Fractionation Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Human Blood Plasma Fractionation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Human Blood Plasma Fractionation Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Human Blood Plasma Fractionation Market Share by Region (2017-2022) Table 10. Global Human Blood Plasma Fractionation Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Human Blood Plasma Fractionation Market Share by Region (2023-2028) Table 12. Human Blood Plasma Fractionation Market Trends Table 13. Human Blood Plasma Fractionation Market Drivers Table 14. Human Blood Plasma Fractionation Market Challenges Table 15. Human Blood Plasma Fractionation Market Restraints Table 16. Global Human Blood Plasma Fractionation Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Human Blood Plasma Fractionation Market Share by Players (2017-2022) Table 18. Global Top Human Blood Plasma Fractionation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Blood Plasma Fractionation as of 2021) Table 19. Ranking of Global Top Human Blood Plasma Fractionation Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Human Blood Plasma Fractionation Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Human Blood Plasma Fractionation Product Solution and Service Table 23. Date of Enter into Human Blood Plasma Fractionation Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Human Blood Plasma Fractionation Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Human Blood Plasma Fractionation Revenue Market Share by Type (2017-2022) Table 27. Global Human Blood Plasma Fractionation Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Human Blood Plasma Fractionation Revenue Market Share by Type (2023-2028) Table 29. Global Human Blood Plasma Fractionation Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Human Blood Plasma Fractionation Revenue Market Share by Application (2017-2022) Table 31. Global Human Blood Plasma Fractionation Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Human Blood Plasma Fractionation Revenue Market Share by Application (2023-2028) Table 33. North America Human Blood Plasma Fractionation Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Human Blood Plasma Fractionation Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Human Blood Plasma Fractionation Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Human Blood Plasma Fractionation Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Human Blood Plasma Fractionation Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Human Blood Plasma Fractionation Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Human Blood Plasma Fractionation Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Human Blood Plasma Fractionation Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Human Blood Plasma Fractionation Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Human Blood Plasma Fractionation Market Size by Country (2023-2028) & (US$ Million) Table 43. Takeda Company Detail Table 44. Takeda Business Overview Table 45. Takeda Human Blood Plasma Fractionation Product Table 46. Takeda Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 47. Takeda Recent Development Table 48. CSL Company Detail Table 49. CSL Business Overview Table 50. CSL Human Blood Plasma Fractionation Product Table 51. CSL Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 52. CSL Recent Development Table 53. Grifols Company Detail Table 54. Grifols Business Overview Table 55. Grifols Human Blood Plasma Fractionation Product Table 56. Grifols Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 57. Grifols Recent Development Table 58. Octapharma Company Detail Table 59. Octapharma Business Overview Table 60. Octapharma Human Blood Plasma Fractionation Product Table 61. Octapharma Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 62. Octapharma Recent Development Table 63. Kedrion Company Detail Table 64. Kedrion Business Overview Table 65. Kedrion Human Blood Plasma Fractionation Product Table 66. Kedrion Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 67. Kedrion Recent Development Table 68. LFB Group Company Detail Table 69. LFB Group Business Overview Table 70. LFB Group Human Blood Plasma Fractionation Product Table 71. LFB Group Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 72. LFB Group Recent Development Table 73. Biotest Company Detail Table 74. Biotest Business Overview Table 75. Biotest Human Blood Plasma Fractionation Product Table 76. Biotest Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 77. Biotest Recent Development Table 78. BPL Company Detail Table 79. BPL Business Overview Table 80. BPL Human Blood Plasma Fractionation Product Table 81. BPL Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 82. BPL Recent Development Table 83. RAAS Company Detail Table 84. RAAS Business Overview Table 85. RAAS Human Blood Plasma Fractionation Product Table 86. RAAS Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 87. RAAS Recent Development Table 88. CBPO Company Detail Table 89. CBPO Business Overview Table 90. CBPO Human Blood Plasma Fractionation Product Table 91. CBPO Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 92. CBPO Recent Development Table 93. Hualan Bio Company Detail Table 94. Hualan Bio Business Overview Table 95. Hualan Bio Human Blood Plasma FractionationProduct Table 96. Hualan Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 97. Hualan Bio Recent Development Table 98. Tiantan Bio Company Detail Table 99. Tiantan Bio Business Overview Table 100. Tiantan Bio Human Blood Plasma FractionationProduct Table 101. Tiantan Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 102. Tiantan Bio Recent Development Table 103. Shuanglin Bio Company Detail Table 104. Shuanglin Bio Business Overview Table 105. Shuanglin Bio Human Blood Plasma FractionationProduct Table 106. Shuanglin Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 107. Shuanglin Bio Recent Development Table 108. Boya Bio Company Detail Table 109. Boya Bio Business Overview Table 110. Boya Bio Human Blood Plasma FractionationProduct Table 111. Boya Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 112. Boya Bio Recent Development Table 113. Yuanda Shuyang Company Detail Table 114. Yuanda Shuyang Business Overview Table 115. Yuanda Shuyang Human Blood Plasma FractionationProduct Table 116. Yuanda Shuyang Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 117. Yuanda Shuyang Recent Development Table 118. Weiguang Bio Company Detail Table 119. Weiguang Bio Business Overview Table 120. Weiguang Bio Human Blood Plasma FractionationProduct Table 121. Weiguang Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 122. Weiguang Bio Recent Development Table 123. Nanyue Bio Company Detail Table 124. Nanyue Bio Business Overview Table 125. Nanyue Bio Human Blood Plasma FractionationProduct Table 126. Nanyue Bio Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 127. Nanyue Bio Recent Development Table 128. KM Biologics Company Detail Table 129. KM Biologics Business Overview Table 130. KM Biologics Human Blood Plasma FractionationProduct Table 131. KM Biologics Revenue in Human Blood Plasma Fractionation Business (2017-2022) & (US$ Million) Table 132. KM Biologics Recent Development Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Global Human Blood Plasma Fractionation Market Share by Type: 2021 VS 2028 Figure 2. Immune Globulin Features Figure 3. Coagulation Factor Features Figure 4. Albumin Features Figure 5. Other Features Figure 6. Global Human Blood Plasma Fractionation Market Share by Application in 2021 & 2028 Figure 7. Hospital Case Studies Figure 8. Retail Pharmacy Case Studies Figure 9. Other Case Studies Figure 10. Human Blood Plasma Fractionation Report Years Considered Figure 11. Global Human Blood Plasma Fractionation Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Human Blood Plasma Fractionation Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Human Blood Plasma Fractionation Market Share by Region: 2021 VS 2028 Figure 14. Global Human Blood Plasma Fractionation Market Share by Players in 2021 Figure 15. Global Top Human Blood Plasma Fractionation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Blood Plasma Fractionation as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Human Blood Plasma Fractionation Revenue in 2021 Figure 17. North America Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Human Blood Plasma Fractionation Market Share by Country (2017-2028) Figure 19. United States Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Human Blood Plasma Fractionation Market Share by Country (2017-2028) Figure 23. Germany Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Human Blood Plasma Fractionation Market Share by Region (2017-2028) Figure 31. China Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Human Blood Plasma Fractionation Market Share by Country (2017-2028) Figure 39. Mexico Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Human Blood Plasma Fractionation Market Share by Country (2017-2028) Figure 43. Turkey Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Human Blood Plasma Fractionation Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Takeda Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 46. CSL Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 47. Grifols Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 48. Octapharma Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 49. Kedrion Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 50. LFB Group Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 51. Biotest Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 52. BPL Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 53. RAAS Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 54. CBPO Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 55. Hualan Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 56. Tiantan Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 57. Shuanglin Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 58. Boya Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 59. Yuanda Shuyang Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 60. Weiguang Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 61. Nanyue Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 62. KM Biologics Revenue Growth Rate in Human Blood Plasma Fractionation Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Takeda CSL Grifols Octapharma Kedrion LFB Group Biotest BPL RAAS CBPO Hualan Bio Tiantan Bio Shuanglin Bio Boya Bio Yuanda Shuyang Weiguang Bio Nanyue Bio KM Biologics